News and Announcements
GoCatch Ready to Replace Uber
- Published June 30, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
An Australian investigation into the employment practices of Uber could force it to leave the country, allowing a local competitor to fill the gap. GoCatch CEO and co-founder Andrew Campbell said Uber should be investigated and it would be “good riddance” if the US-based company was forced out of the country.
KEY TAKEAWAYS:
- GoCatch operates in all capital cities and many regional areas.
- It connects registered taxi drivers directly with customers via a smartphone app similar to Uber.
- It claims to have close to 10,000 drivers nationally.
“We’ve got an anti-competitive, monopolistic company from overseas that treats our regulators with contempt, gouges and surge prices consumers, and treats drivers with a complete lack of respect,” he told The New Daily.
Mr Campbell said his company is ready to wholly replace Uber if it leaves, and would be willing to consider employing Australian drivers directly if it became the market-leading ride share app.
“We would certainly be more than happy to fill the gap. We obey Australian law, we pay tax in Australia, we employ Australians [at head office], we pay our GST correctly, we treat our drivers with respect and we price very fairly to consumers.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
